Oxycodone with Prednisone Interaction Details


Brand Names Associated with Oxycodone

  • Combunox® (as a combination product containing Ibuprofen, Oxycodone)
  • Dazidox®
  • Endocet® (as a combination product containing Acetaminophen, Oxycodone)
  • Endocodone®
  • Endodan® (as a combination product containing Aspirin, Oxycodone)
  • ETH-Oxydose®
  • Lynox® (as a combination product containing Acetaminophen, Oxycodone)
  • Magnacet® (as a combination product containing Acetaminophen, Oxycodone)
  • Narvox® (as a combination product containing Acetaminophen, Oxycodone)
  • Oxaydo®
  • Oxecta®
  • Oxycet® (as a combination product containing Acetaminophen, Oxycodone)
  • Oxycodone
  • Oxycontin®
  • Oxyfast®
  • OxyIR®
  • Percocet® (as a combination product containing Acetaminophen, Oxycodone)
  • Percodan® (as a combination product containing Aspirin, Oxycodone)
  • Percolone®
  • Perloxx® (as a combination product containing Acetaminophen, Oxycodone)
  • Primlev® (as a combination product containing Acetaminophen, Oxycodone)
  • Roxicet® (as a combination product containing Acetaminophen, Oxycodone)
  • Roxicodone®
  • Roxiprin® (as a combination product containing Aspirin, Oxycodone)
  • Targiniq® ER (as a combination product containing naloxone, oxycodone)
  • Taxadone® (as a combination product containing Acetaminophen, Oxycodone)
  • Tylox® (as a combination product containing Acetaminophen, Oxycodone)
  • Xartemis XR® (as a combination product containing Acetaminophen, Oxycodone)
  • Xolox® (as a combination product containing Acetaminophen, Oxycodone)
  • Xtampza® ER

Brand Names Associated with Prednisone

  • Cortan®
  • Deltasone®
  • Orasone®
  • Prednisone
  • Prednisone Intensol
  • Rayos®
  • Sterapred®
  • Sterapred® DS

Medical Content Editor
Last updated Nov 13, 2023


Curious for more information about this interaction?

Ask our pharmacists directly!

Reach out to us

Interaction Effect

Decreased oxycodone exposure


Interaction Summary

Use caution when initiating or discontinuing concurrent treatment with oxycodone (a CYP3A4 substrate) with a CYP3A4 inducer. Concomitant use with a CYP3A4 inducer may reduce oxycodone efficacy or cause abstinence syndrome in physically dependent patients. Conversely, discontinuation of a CYP3A4 inducer may decrease oxycodone clearance and increase drug levels, which can manifest as life-threatening or fatal respiratory depression. If concomitant use with a CYP3A4 inducer is clinically required, monitor patients frequently for signs of opioid withdrawal and decreased efficacy. Consider dose adjustments until stable plasma concentrations are achieved. Continue patient monitoring during discontinuation of concomitant CYP3A4 inducers. Oxycodone AUC and Cmax values decreased by 86% and 63%, respectively, with coadministration of rifampin, a CYP3A4 inducer, especially for signs of respiratory depression . Consider prescribing naloxone for the emergency treatment of opioid overdose .


Severity

Major


Onset

Unspecified


Evidence

Theoretical


How To Manage Interaction

Use caution when initiating or discontinuing concurrent treatment with oxycodone and a CYP3A4 inducer. Concomitant use with a CYP3A4 inducer may reduce oxycodone efficacy or cause abstinence syndrome in physically dependent patients. Conversely, discontinuation of a CYP3A4 inducer may decrease oxycodone clearance and increase drug levels, which can manifest as life-threatening or fatal respiratory depression. If concomitant use with a CYP3A4 inducer is clinically required, monitor patients frequently for signs of opioid withdrawal and decreased efficacy. Consider dosage adjustments until stable plasma concentrations are achieved. Continue patient monitoring during discontinuation of concomitant CYP3A4 inducers, especially for signs of respiratory depression . Consider prescribing naloxone for the emergency treatment of opioid overdose .


Mechanism Of Interaction

Induction of CYP3A4-mediated oxycodone metabolism


Literature Reports

A) Oxycodone AUC and Cmax values decreased by 86% and 63%, respectively, with coadministration of rifampin, a CYP3A4 inducer .

Oxycodone Overview

  • Oxycodone is used to relieve moderate to severe pain. Oxycodone extended-release tablets and extended-release capsules are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. Oxycodone extended-release tablets and extended-release capsules should not be used to treat pain that can be controlled by medication that is taken as needed. Oxycodone extended-release tablets, extended-release capsules, and concentrated solution should only be used to treat people who are tolerant (used to the effects of the medication) to opioid medications because they have taken this type of medication for at least one week. Oxycodone is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

  • Oxycodone is also available in combination with acetaminophen (Oxycet, Percocet, Roxicet, Xartemis XR, others); aspirin (Percodan); and ibuprofen. This monograph only includes information about the use of oxycodone alone. If you are taking an oxycodone combination product, be sure to read information about all the ingredients in the product you are taking and ask your doctor or pharmacist for more information.

See More information Regarding Oxycodone

Prednisone Overview

  • Prednisone is used alone or with other medications to treat the symptoms of low corticosteroid levels (lack of certain substances that are usually produced by the body and are needed for normal body functioning). Prednisone is also used to treat other conditions in patients with normal corticosteroid levels. These conditions include certain types of arthritis; severe allergic reactions; multiple sclerosis (a disease in which the nerves do not function properly); lupus (a disease in which the body attacks many of its own organs); and certain conditions that affect the lungs, skin, eyes, kidneys blood, thyroid, stomach, and intestines. Prednisone is also sometimes used to treat the symptoms of certain types of cancer. Prednisone is in a class of medications called corticosteroids. It works to treat patients with low levels of corticosteroids by replacing steroids that are normally produced naturally by the body. It works to treat other conditions by reducing swelling and redness and by changing the way the immune system works.

See More information Regarding Prednisone

Return To Our Drug Interaction Homepage


Feedback, Question Or Comment About This Information?

Ask , our medical editor, directly! He's always more than happy to assist.


Definitions

Severity Categories

Contraindicated

These drugs, generally, should not be used together simultaneously due to the high risk of severe adverse effects. Combining these medications can lead to dangerous health outcomes and should be strictly avoided unless otherwise instructed by your provider.


Major

This interaction could result in very serious and potentially life-threatening consequences. If you are taking this drug combination, it is very important to be under close medical supervision to minimize severe side effects and ensure your safety. It may be necessary to change a medication or dosage to prevent harm.


Moderate

This interaction has the potential to worsen your medical condition or alter the effectiveness of your treatment. It's important that you are monitored closely and you potentially may need to make adjustments in your treatment plan or drug dosage to maintain optimal health.


Minor

While this interaction is unlikely to cause significant problems, it could intensify side effects or reduce the effectiveness of one or both medications. Monitoring for changes in symptoms and your condition is recommended, and adjustments may be made if needed to manage any increased or more pronounced side effects.


Onset

Rapid: Onset of drug interaction typically occurs within 24 hours of co-administration.

Delayed: Onset of drug interaction typically occurs more than 24 hours after co-administration.


Evidence

Level of documentation of the interaction.

Established: The interaction is documented and substantiated in peer-reviewed medical literature.

Theoretical: This interaction is not fully supported by current medical evidence or well-documented sources, but it is based on known drug mechanisms, drug effects, and other relevant information.


How To Manage The Interaction

Provides a detailed discussion on how patients and clinicians can approach the identified drug interaction as well as offers guidance on what to expect and strategies to potentially mitigate the effects of the interaction. This may include recommendations on adjusting medication dosages, altering the timing of drug administration, or closely monitoring for specific symptoms.

It's important to note that all medical situations are unique, and management approaches should be tailored to individual circumstances. Patients should always consult their healthcare provider for personalized advice and guidance on managing drug interactions effectively.


Mechanism Of Interaction

The theorized or clinically determined reason (i.e., mechanism) why the drug-drug interaction occurs.


Disclaimer: The information provided on this page is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional regarding your specific circumstances and medical conditions.

Where Does Our Information Come From?

Information for our drug interactions is compiled from several drug compendia, including:

The prescribing information for each drug, as published on DailyMED, is also used. 

Individual drug-drug interaction detail pages contain references specific to that interaction. You can click on the reference number within brackets '[]' to see what reference was utilized.

The information posted is fact-checked by HelloPharmacist clinicians and reviewed quarterly.